COVAGEN— 510(k) K123756

Substantially Equivalent

Covalon Technologies, Ltd.

FDA 510(k) clearance K123756 for COVAGEN, Substantially Equivalent on 2013-08-16. Applicant: Covalon Technologies, Ltd..

Clearance details

Applicant: Covalon Technologies, Ltd.
Product code: Code KGN
Advisory panel: Unknown
Date received: 2012-12-07
Decision date: 2013-08-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Mississauga, Ontario, CA

Download summary PDF View on FDA.gov ↗

Adverse events under product code KGN

product code KGN

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.